Table 1.
Study Population Characteristics (n=558)
| Demographic and Behavioral Variables | Mean ± SD or n (%) |
|---|---|
| Age, yr | 56 ± 7 |
| White / Caucasian (versus Other) | 546 (97.9) |
| Postmenopausal | 436 (78.1) |
| Current hormone use* | 183 (32.8) |
| Current smoker | 62 (11.2) |
| Body mass index (kg/m2) | 25.1 ± 4.3 |
| Physical activity, MET-hrs/week | 15.0 ± 17.5 |
| Daily Energy and Macronutrient Intake | |
| Energy intake, kcal | 1766 ± 494 |
| Alcohol intake, % kcal | 2.1 ± 3.8 |
| Carbohydrate, %kcal | 50.4 ± 8.6 |
| Protein, %kcal | 18.9 ± 3.2 |
| Dairy protein, % kcal | 3.7 ± 1.9 |
| Total fat, %kcal | 31.2 ± 6.0 |
| Saturated fat, % kcal | 10.5 ± 2.5 |
| Trans fat, % kcal | 1.5 ± 0.6 |
| Monounsaturated fat, %kcal | 12.0 ± 2.7 |
| Polyunsaturated fat, %kcal | 5.9 ± 1.6 |
| Biomarkers | |
| IGF-I, total, ng/mL | 152.3 ± 50.7 |
| IGF-I, free, ng/mL | 0.5 ± 0.3 |
| IGFBP-1, ng/mL | 41.5 ± 28.1 |
| IGFBP-2, ng/mL | 593.2 ± 352.0 |
| IGFBP-3, ng/mL | 4,676.8 ± 1,001.7 |
| CRP, mg/dL | 1.4 ± 3.6 |
| Adiponectin, μg/mL | 18.3 ± 7.4 |
| Resistin, ng/mL | 17.5 ± 11.9 |
| Leptin, ng/mL | 19.5 ± 13.0 |
| Soluble leptin receptor (sOB-R), ng/mL | 34.9 ± 11.3 |
| Insulin, μU/mL | 6.8 ± 5.3 |
| HbA1C, % | 5.2 ± 0.4 |
| IL-18, pg/mL | 300.7 ± 187.3 |
Current hormone therapy (HT) (versus past/never), body mass index (BMI)